NCT05789576View on ClinicalTrials.gov

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

July 19, 2023

Conditions
Psoriasis
Interventions
DRUG

VTAMA (tapinarof) cream, 1%

VTAMA (tapinarof) cream, 1% applied topically once daily

Trial Locations (10)

11415

Dermavant Investigative Site, Kew Gardens

20850

Dermavant Investigative Sites, Rockville

31217

Dermavant Investigative Site, Macon

43302

Dermavant Investigative Site, Marion

48202

Dermavant Investigative Site, Detroit

48326

Dermavant Investigative Site, Auburn Hills

60602

Dermavant Investigative Site, Chicago

76014

Dermavant Investigative Site, Arlington

89144

Dermavant Investigative Site, Las Vegas

03801

Dermavant Investigative Site, Portsmouth

All Listed Sponsors
lead

Organon and Co

INDUSTRY